Jeremy Wade<\/p><\/div>\n

The new inlay “solves a couple of problems,” Wade says. It enables drug companies to accomplish labeling directly on their products, he explains, while allowing converters to buy one type of inlay for all their needs or purposes instead of having to source multiple inlays for very specific uses. Traditionally, converters often had to customize inlays for specific pharmaceutical customers; some might require very small labels, while others might need to apply wet inlays and others might prefer shrink-sleeve labels.<\/p>\n

The company offers the inlays on rolls in one of two orientation options: either as a wide-edge leading format of the inlay, or as a narrow-edge leading, in which the inlay’s smaller edge matches the roll’s smaller edge. This provides converters with a choice for how to assemble labels using inlay rolls. Some converters require the narrow edge leading format for their label manufacturing process, Wade says.<\/p>\n

Tageos reports that the new inlay enables high performance in its small size, based on its proprietary antenna design created in the company’s rapid product-development process. The 90-day design, in this case, required extensive work and testing in an anechoic chamber to meet the specification’s complex requirements, Reese says. The built-in UCODE 9 chip enables high sensitivity values, he notes, allowing for a smaller antenna and thus helping the inlay to achieve its small size.<\/p>\n

Reese says several companies now have samples of the inlay in hand, which they are currently testing and using. Those businesses include converters, as well as pharmaceutical firms and systems integrators like Kit Check. Tageos expects to see commercially available labels using the inlays on the market by the fourth quarter of this year, and he reports that feedback from customers has been good.<\/p>\n

Since its development, the EOS-202 U9 inlay has attracted attention from other markets for applications beyond pharmaceuticals and healthcare, Reese reports, including for tracking retail cosmetics. Some drug companies have reportedly been delaying RFID adoption until inlays were available that could accomplish the tagging of the entire range of materials they produce. “This helps the adoption process of the technology,” he states.<\/p>\n

 <\/p>\n","protected":false},"excerpt":{"rendered":"

Drug companies, label converters and systems integrators are testing or employing Tageos’s ARC Spec S-certified UHF RFID inlay for tracking single-unit drugs and small devices, no matter the material and even around liquids.<\/p>\n","protected":false},"author":196612,"featured_media":191859,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","_ppp_document_settings_meta":"","__cvm_playback_settings":[],"__cvm_video_id":"","footnotes":""},"categories":[472],"tags":[124,48,139,138,21],"acf":[],"yoast_head":"\n